{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ketoconazole-placebo", "query": { "intervention": "ketoconazole-placebo" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 27, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ketoconazole-placebo&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-19T11:41:49.849Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00419783", "title": "A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Bilastine", "type": "DRUG" }, { "name": "Bilastine & Ketoconazole", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Faes Farma, S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 30, "start_date": "2006-08", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2012-04-05", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00419783" }, { "nct_id": "NCT02147964", "title": "ITT-5 Mechanisms of Spermatogenesis in Man", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gonadotropin Deficiency" ], "interventions": [ { "name": "Testosterone 1% Gel", "type": "DRUG" }, { "name": "Acyline", "type": "DRUG" }, { "name": "Dutasteride", "type": "DRUG" }, { "name": "Ketoconazole", "type": "DRUG" }, { "name": "HCG", "type": "DRUG" }, { "name": "placebo dutasteride", "type": "DRUG" }, { "name": "placebo ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 0, "start_date": "2019-06", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2019-12-18", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02147964" }, { "nct_id": "NCT00768690", "title": "A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HCV Infection" ], "interventions": [ { "name": "ABT-333", "type": "DRUG" }, { "name": "ketoconazole", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 45, "start_date": "2008-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-10-13", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Waukegan, Illinois", "locations": [ { "city": "Waukegan", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00768690" }, { "nct_id": "NCT00675714", "title": "Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Burns" ], "interventions": [ { "name": "Stable Isotope Infusion Study", "type": "PROCEDURE" }, { "name": "Collection of blood and tissues", "type": "PROCEDURE" }, { "name": "Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI", "type": "PROCEDURE" }, { "name": "Humatrope", "type": "DRUG" }, { "name": "Ketoconazole", "type": "DRUG" }, { "name": "Oxandrolone", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Oxandrolone and propranolol combined", "type": "DRUG" }, { "name": "Humatrope and propranolol combined", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Exercise--Hospital supervised intensive exercise program", "type": "BEHAVIORAL" }, { "name": "Home exercise program", "type": "BEHAVIORAL" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BEHAVIORAL" ], "sponsor": "The University of Texas Medical Branch, Galveston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "80 Years", "sex": "ALL", "summary": "Up to 80 Years" }, "enrollment_count": 1126, "start_date": "2004-01", "completion_date": "2019-07-15", "has_results": false, "last_update_posted_date": "2019-11-29", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Galveston, Texas", "locations": [ { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00675714" }, { "nct_id": "NCT02198170", "title": "A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "ketoconazole-placebo", "type": "DRUG" }, { "name": "placebo-ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 18, "start_date": "2011-02", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2015-02-13", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02198170" }, { "nct_id": "NCT03142893", "title": "Hormonal Mechanisms of Sleep Restriction - Axis Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sleep Restriction" ], "interventions": [ { "name": "Ketoconazole Pill", "type": "DRUG" }, { "name": "Ganirelix", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Dexamethasone Injection", "type": "DRUG" }, { "name": "Cosyntropin Injectable Product", "type": "DRUG" }, { "name": "Recombinant Human Luteinizing Hormone", "type": "DRUG" }, { "name": "Hydrocortisone Injection", "type": "DRUG" }, { "name": "Gonadorelin", "type": "DRUG" }, { "name": "Corticorelin", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" }, { "name": "Saline Solution", "type": "DRUG" }, { "name": "Saline Solution for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peter y. Liu", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "22 Years to 45 Years · Male only" }, "enrollment_count": 80, "start_date": "2017-05-08", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03142893" }, { "nct_id": "NCT00914121", "title": "Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "SKI-606", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 60, "start_date": "2009-06", "completion_date": "2009-08", "has_results": false, "last_update_posted_date": "2009-09-02", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00914121" }, { "nct_id": "NCT03471364", "title": "Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Malignant Neoplasm" ], "interventions": [ { "name": "Ketoconazole", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Placebo Administration", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2018-09-25", "completion_date": "2024-09-15", "has_results": false, "last_update_posted_date": "2025-10-08", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 6, "location_summary": "Danville, Illinois • Urbana, Illinois • Rochester, Minnesota + 3 more", "locations": [ { "city": "Danville", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Saint Louis Park", "state": "Minnesota" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03471364" }, { "nct_id": "NCT01215292", "title": "ITT4 Intratesticular Hormonal Milieu in Man (ITT4)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy Males" ], "interventions": [ { "name": "Acyline", "type": "DRUG" }, { "name": "Testosterone gel", "type": "DRUG" }, { "name": "ketoconazole 400", "type": "DRUG" }, { "name": "Ketoconazole 800", "type": "DRUG" }, { "name": "Dutasteride", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Placebo ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 46, "start_date": "2011-01", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2014-03-31", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01215292" }, { "nct_id": "NCT02256865", "title": "Hormonal Mechanisms of Sleep Restriction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Insulin Resistance" ], "interventions": [ { "name": "Ketoconazole", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Testosterone", "type": "DRUG" }, { "name": "Placebo for ketoconazole", "type": "DRUG" }, { "name": "Placebo for hydrocortisone", "type": "DRUG" }, { "name": "Placebo for testosterone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "22 Years to 45 Years · Male only" }, "enrollment_count": 40, "start_date": "2014-10", "completion_date": "2023-10", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-09-19T11:41:49.849Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02256865" } ] }